Press Releases
Unlocking the Possibilities to the Future of Biopharma | 2022 BIO International Convention
This year, the world’s largest biotech partnering event, BIO International Convention, was back in person for the first time since the COVID-19 pandemic. Samsung Biologics participated in the event from June 13-16 in San Diego, California, where it showcased its capabilities as a leading CDMO and actively met with potential clients for future projects. In line with the conference’s theme of “Limitless Together”, the event demonstrated a promising future of breakthrough innovations, paving the way for the next decade of biopharma.
Looking Towards The Next Frontier
Since its foundation in 2011, Samsung Biologics has participated in BIO every year and even when the conference moved online during the COVID-19 outbreak. As the pandemic enters its endemic phase, the company and biotech industry are now looking to what’s next in the latest trends and research.
"We are very excited to participate in the first face-to-face BIO International Convention in three years since the pandemic and to introduce our latest and innovative CDMO capabilities to clients,” said John Rim, CEO and President of Samsung Biologics. "We are continuously evolving to offer services for CDO, mRNA, and multi-modal products to further secure the success drivers for sustainable growth. We are also at the forefront in the biopharma industry to address critical issues like climate change as we aim to provide sustainable and enduring value for people worldwide and contribute to making the world a healthier place for all.”
Driven. For a Sustainable Life.
Samsung Biologics presented its commitment to sustainability at the ESG section of the booth and showcased the company’s promise to become a “Green CDMO.” The company launched its new sustainability branding video, “Driven. For Sustainable Life.”, to mark the promise of building a healthier and sustainable future for all.
“With our aims to become a sustainable partner and a ‘Green CDMO’, we are actively investing in environment-conscious practices and technologies to mitigate the risks of climate change in the greater areas we impact,” said James Choi, EVP and Chief Information & Marketing Officer. “We are also working collaboratively on many global initiatives to help drive the net zero transition across the industry.”
Last year, Samsung Biologics joined together with leaders from global biopharma companies and public sector organizations including the WHO and Unicef, as part of the Sustainable Markets Initiative (SMI), convened by His Royal Highness The Prince of Wales, to accelerate the delivery of net zero and establish sustainable healthcare to improve individual, societal, and planetary health.
“Samsung Biologics is also working at an industry-level to drive successful decarbonization,” Choi added. "We joined the Frontier 1.5D project to develop a climate risk management model, which affirms our commitment to shaping climate-resilient practices and policies across all value chains in the pharmaceutical and healthcare sectors.”
Addressing Key Insights into the Next Blockbuster
In addition to exhibition booths and networking receptions, over 100+ panel sessions covered various industry topics, such as next-generation biotherapeutics, mRNA, public policy, patient advocacy, and more.
Pierre Catignol, Executive Vice President and Head of the Manufacturing Center, participated in a panel session to address key insights into mRNA and give guidance on what to look for in a CDMO partner.
During the session, Catignol introduced the unique capabilities of Samsung Biologics and how it offers fully integrated mRNA manufacturing services all at a single site in Songdo.
Limitless Together to Bring New Opportunities
“BIO International is a place where bio-industry professionals and experts can come together to explore ways to cooperate and create new opportunities. This year’s theme of ‘Limitless Together’ is to show the cross-boundary collaboration of bio officials and the unlimited challenges in unknown areas,” said Adela Wilson from BIO. “Samsung Biologics’ performance was remarkable, both with its creative booth design and outstanding service competitiveness.”
Samsung Biologics is at the forefront of building a sustainable future for all. By leveraging its world’s largest manufacturing capacity and continuous innovation, the company will strive to make innovative biologics accessible to all and create a healthier future.
Driven. For Life.
Related Contents
Samsung BIO Insight The Power of One I Samsung Biologics’ mRNA Capabilities
Life @ Samsung Biologics Driven. For Climate Action
This year, the world’s largest biotech partnering event, BIO International Convention, was back in person for the first time since the COVID-19 pandemic. Samsung Biologics participated in the event from June 13-16 in San Diego, California, where it showcased its capabilities as a leading CDMO and actively met with potential clients for future projects. In line with the conference’s theme of “Limitless Together”, the event demonstrated a promising future of breakthrough innovations, paving the way for the next decade of biopharma.
Looking Towards The Next Frontier
Since its foundation in 2011, Samsung Biologics has participated in BIO every year and even when the conference moved online during the COVID-19 outbreak. As the pandemic enters its endemic phase, the company and biotech industry are now looking to what’s next in the latest trends and research.
"We are very excited to participate in the first face-to-face BIO International Convention in three years since the pandemic and to introduce our latest and innovative CDMO capabilities to clients,” said John Rim, CEO and President of Samsung Biologics. "We are continuously evolving to offer services for CDO, mRNA, and multi-modal products to further secure the success drivers for sustainable growth. We are also at the forefront in the biopharma industry to address critical issues like climate change as we aim to provide sustainable and enduring value for people worldwide and contribute to making the world a healthier place for all.”
Driven. For a Sustainable Life.
Samsung Biologics presented its commitment to sustainability at the ESG section of the booth and showcased the company’s promise to become a “Green CDMO.” The company launched its new sustainability branding video, “Driven. For Sustainable Life.”, to mark the promise of building a healthier and sustainable future for all.
“With our aims to become a sustainable partner and a ‘Green CDMO’, we are actively investing in environment-conscious practices and technologies to mitigate the risks of climate change in the greater areas we impact,” said James Choi, EVP and Chief Information & Marketing Officer. “We are also working collaboratively on many global initiatives to help drive the net zero transition across the industry.”
Last year, Samsung Biologics joined together with leaders from global biopharma companies and public sector organizations including the WHO and Unicef, as part of the Sustainable Markets Initiative (SMI), convened by His Royal Highness The Prince of Wales, to accelerate the delivery of net zero and establish sustainable healthcare to improve individual, societal, and planetary health.
“Samsung Biologics is also working at an industry-level to drive successful decarbonization,” Choi added. "We joined the Frontier 1.5D project to develop a climate risk management model, which affirms our commitment to shaping climate-resilient practices and policies across all value chains in the pharmaceutical and healthcare sectors.”
Addressing Key Insights into the Next Blockbuster
In addition to exhibition booths and networking receptions, over 100+ panel sessions covered various industry topics, such as next-generation biotherapeutics, mRNA, public policy, patient advocacy, and more.
Pierre Catignol, Executive Vice President and Head of the Manufacturing Center, participated in a panel session to address key insights into mRNA and give guidance on what to look for in a CDMO partner.
During the session, Catignol introduced the unique capabilities of Samsung Biologics and how it offers fully integrated mRNA manufacturing services all at a single site in Songdo.
Limitless Together to Bring New Opportunities
“BIO International is a place where bio-industry professionals and experts can come together to explore ways to cooperate and create new opportunities. This year’s theme of ‘Limitless Together’ is to show the cross-boundary collaboration of bio officials and the unlimited challenges in unknown areas,” said Adela Wilson from BIO. “Samsung Biologics’ performance was remarkable, both with its creative booth design and outstanding service competitiveness.”
Samsung Biologics is at the forefront of building a sustainable future for all. By leveraging its world’s largest manufacturing capacity and continuous innovation, the company will strive to make innovative biologics accessible to all and create a healthier future.
Driven. For Life.
Related Contents
Samsung BIO Insight The Power of One I Samsung Biologics’ mRNA Capabilities
Life @ Samsung Biologics Driven. For Climate Action